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Background: The Global Initiative defines COPD for chronic obstructive lung disease as an entirely preventable
and treatable disease characterized by sputum production, bacterial colonisation, neutrophilic bronchial airway
inflammation and poor health status. The World Health Organization (WHO) estimates that COPD will become the
fourth-most common cause of death worldwide, just behind ischemic heart disease, cerebrovascular disease and
HIV/AIDS, by 2030. The aim of this study was to determine the main structure feature of sputum potentially
pathogenic microorganisms in subjects with COPD during the clinical stable state.
Methods: We employed a molecular genetics-based investigation of the bacteria community, including DNA
isolation, PCR amplification and DGGE profiling. PCR-denaturing gradient gel electrophoresis (DGGE) with universal
primers targeting the V3 region of the 16S rRNA gene was employed to characterize the overall COPD patient
sputum microbiota composition, and some excised gel bands were cloned for sequencing. Real-time PCR was
further utilized to quantitatively analyze the subpopulation of microbiota using group-specific primers targeting
Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa.
Results: The DGGE profiles of two groups displayed significant differences between COPD and healthy groups
(P < 0.05). Real-time PCR revealed significant increases of Streptococcus pneumoniae, Klebsiella pneumoniae and
Pseudomonas aeruginosa (P < 0.05) in the COPD group compared with the healthy group.
Conclusion: This study revealed strong relationship between alterations of sputum microbiota and COPD. By
determining the content of several types of bacteria, we can provide evidence to aid in the diagnosis and
treatment of COPD.Background
Chronic obstructive pulmonary disease (COPD) is catego-
rized by the severity of the airflow obstruction based on
the patient’s predicted forced expiratory volume in one
second [1,2]. COPD involves a variety of pathological pro-
cesses, such as chronic bronchitis, chronic bronchiolitis
and emphysema [3]. These pathological processes may
occur individually or in combination. Acute exacerbations
are common and occur once to three times per year,* Correspondence: jimxin0295@163.com
†Equal contributors
1Biotechnology Department, Dalian Medical University, 9 Western Section,
Lvshun South Street, Dalian, P.R. China
Full list of author information is available at the end of the article
© 2014 Wu et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.which leads to most of the observed morbidity and mor-
tality among patients [3,4]. Bronchial infection is the most
common cause and patients with frequent exacerbations
appear to have a more rapid decline in quality of life [5].
In addition, acute exacerbations account for frequent
medical visits, hospital admission [6] and death in patients
with COPD. A longer-term legacy of an acute exacerba-
tion that is also seen is the persistence of bacteria in the
lower airway after an acute exacerbation, which is associ-
ated with increased inflammation and can lead to the pro-
gressive loss of lung function.
Most COPD exacerbations are infectious and largely
either bacterial, though viral pathogens have also been
isolated during exacerbations [7]. Haemophilus influenza.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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monas aeruginosa [8,9] are the most frequently isolated
bacterial agents during exacerbations. A large number of
studies have indicated that one or more pathogens can be
isolated from patients’ sputum during exacerbations. In a
longitudinal study performed by Sethi and his colleagues
of sputum microbiology in moderate to severe category
COPD patients with an average FEV1 of 47, COPD exac-
erbations were commonly observed with new bacterial
strains: Haemophilus influenza or Moraxella catarrhalis.
This study also demonstrated that a great many instances
where sputum microbiology were culture positive even
without a clear diagnosis of exacerbation [10].
David Soll [11] defined polymicrobial diseases as those
diseases that can occur with organisms from different
kingdoms, from different genera within a kingdom and
finally from different substrains within a strain. The clas-
sification of polymicrobial infection refers to polyviral
infections, polybacterial infections, viral and bacterial in-
fections, polymicrobial mycotic infections, and infections
resulting from microbe-induced immunosuppression.
Typically, polymicrobial infection can lead to a more
severe situation than those originated from a single etio-
logic agent. Polymicrobial infections commonly occur
in the oral cavity, the upper and lower airway, and the
gastrointestinal tract. More and more diseases have
already been defined as polymicrobial. However, there
are still many diseases that remain to be proven as poly-
microbial. In some cases, polymicrobial diseases are not
sensitive to antibiotic treatment. Thus, it is important
to identify the etiologic agents for polymicrobial infec-
tion and the part that each agent may play in the course
of disease.
This study was aimed at characterizing the complex mi-
crobial diversity profile of the patient with COPD and
healthy individuals. PCR-DGGE analysis provided insight
into the overall microbiota community, whereas real-time
PCR was used to quantify Streptococcus pneumoniae, Kleb-
siella pneumoniae, and Pseudomonas aeruginosa to observe
changes at the specific genus level.
Methods
Ethics considerations
The study was approved by the Medical Ethics Commit-
tee of the First Affiliated Hospital of Dalian Medical
University (Permit Number: KY2012–36).
Sputum specimen collection
Twenty subjects (10 COPD patients and 10 healthy volun-
teers) aged 60–80 years participated in the study. The clin-
ical samples were diagnosed and obtained from the First
Affiliated Hospital of Dalian Medical University from
August to October 2012. All patients had not received
any antibiotic treatment. Written informed consent wasobtained from all participants who were treated in compli-
ance with the Helsinki Declaration on the participation of
human subjects in medical research. Prior to the investiga-
tion, sputum samples were stored at – 80°C.
DNA extraction
Prior to DNA extraction, all of the sputum samples were
digested and decontaminated with N-acetyl-L-cysteine
(NALC)-NaOH. Two volumes of NALC-NaOH solution
(4% NaOH, 1.45% Na-citrate, and 0.5% NALC) were
mixed with each sputum specimen in a sterilized test tube
for digestion. The mixture was cultured at room
temperature for 15 minutes with gentle shaking. Ten vol-
umes of 6.7 mM phosphate buffer solution (PBS, pH 7.4)
were added and the mixture centrifuged at 3,000 x g for
15 minutes at room temperature. The supernatant was
discarded, and the pellet washed twice with PBS. Total
bacterial DNA was extracted using QIAmp DNA Mini
and Blood Mini kits (Qiagen, CA, USA) according to the
manufacturer’s instructions. Briefly, a 100-μl aliquot of the
decontaminated sputum specimen was mixed with an
equal volume of deionized water and centrifuged for
10 min at 14,000 × g. The pellet was resuspended in ATL
buffer (Qiagen, CA, USA) containing 1 mg/ml proteinase
K and incubated at 56°C for 60 min. Subsequently, two cy-
cles of freeze-thawing were performed to lyse the myco-
bacterial cells. DNA was purified and collected for further
detection. The integrity of the nucleic acids was deter-
mined visually by 1% agarose gels electrophoresis contain-
ing ethidium bromide. DNA extraction and PCR
amplification were performed in a specific PCR diagnosis
room to prevent cross-contamination of nucleic acids.
PCR amplification
Primers targeting the variable V3 region of 16S rRNA gene
were applied, and the procedure performed following our
previous publicized method [12]. Each 50 μl of the PCR
reaction mixture contained 20 pmol of each primer,
20 mM of dNTP mixture, 5 μl of 10 × Ex Taq buffer
(Mg2+ plus), 5 μl of 1% BSA, 2.5 U of Ex Taq DNA poly-
merase (TakaRa, Japan), and 2 μl of DNA template
(approximately 200 ng). PCR amplification was performed
in an automated thermocycler (Thermo USA). The PCR
program was as follows: 94°C for 5 min; 30 cycles of 94°C
for 30 s, 54°C for 30 s, and 72°C for 30 s; and lastly, 72°C
for 7 min. The size of the obtained amplicons was checked
through electrophoresis in a 2% agarose gel containing
ethidium bromide. The presence of a 200-bp band on the
agarose gel indicated successful amplification.
Denaturing gradient gel electrophoresis and DGGE
profiles analysis
PCR-based DGGE analysis was conducted to rapidly detect
microbial community structure, followed by subsequent
Table 1 16S rRNA PCR primers used in real-time PCR
Bacterium Primer Sequence(5’- 3’) References
Streptococcus pneumoniae F ACG CAA CTG ACG
AGT GTG AC
[18]
R GAT CGC GAC ACC
GAA CTA AT
Klebsiella pneumoniae F GAG GTC GGT GGT
TCA AGT C
[19]
R TCG CAG TAA AGA
TGG TGG AG
Pseudomonas aeruginosa F ATG GAA ATG CTG
AAA TTC GGC
[20]
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DGGE analysis was performed by a Universal Mutation
Detection System (Bio-Rad, USA) with an 8% polyacryl-
amide gel containing a 35–65% gradient of urea and form-
amide (a 100% denaturing solution contained 40% [v/v]
formamide and 7.0 mM urea) as reported [13]. The ratio of
acrylamide to bisacrylamide was 37.5:1. The electrophoresis
was run at 200 V for 10 min, followed by a constant
temperature of 60°C at 65 V for 7 hours. The gels were
stained with ethidium bromide solution for 60 min, washed
with deionized water, and viewed with a Gel Documenta-
tion System (Bio-Rad, USA) and photographed on a UV
transilluminator.
The DGGE gel images were analyzed using Phoretix
1D (Single Gel Dendrogram) software (Phoretix, New-
castle upon Tyne, UK) [14]. The analysis took into
account the number of bands, their gray intensity and
the similarity of DGGE profiles. Similarities were dis-
played graphically as a dendrogram. The clustering algo-
rithm that was used to calculate the dendrogram was an
unweighted pair group method with arithmetic averages
(UPGMA) [15]. The Shannon–Weaver index of diversity
(H’) has been used to determine the diversity of taxa
present in gut microbiota from COPD and healthy
groups [16]. As the data were nonuniformly distributed,
a nonparametric statistical analysis was performed with
the Mann–Whitney U test, where a probability value
P < 0.05 was considered as statistically significant. The
nonparametric statistical analysis was performed using
SPSS (version 11.5). The evenness (E), which reflected
uniformity of the bacterial species distribution, was also
computed. The H’ and E value were calculated with the
following respective formulas: Shannon–Weaver index
(H’) = -∑(Pi) (In Pi); evenness (E) = H’/In S. Pi is the pro-
portion of species/bands for the ith species/band in the
sample [17]. S is the number of bands.
DNA sequencing
To identify some separated and specific bands, a sterile
scalpel was used to cut out the bands from polyacryl-
amide gel under UV illumination. The gel fragments
were washed once in 200 μl of sterile deionized water
and kept in 50 μl of sterile water overnight at 4°C for
diffusion. The extracted gel mix was heated at 90°C for
10 min, and 4 μl of the solution was taken as the DNA
template for re-amplifying by PCR using the original
primers without a GC clamp. The PCR program was
the same as described previously. After purification, the
PCR products were cloned into the PMD18-T Easy
vector (TaKaRa, Japan), transformed into competent
Escherichia coli Nova blue cells, and screened for posi-
tive plasmid insertions according to the manufacturer’s
instructions. A second PCR was utilized to confirm the
successful construction of the recon. The obtained PCRproducts were purified and sent for sequencing (TaKaRa,
Japan). The sequence data were compared directly with
those in GenBank by BLAST search (NCBI).
Real-Time PCR
Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudo-
monas aeruginosa, the important member groups with
their unique characteristics in the sputum, were quantified
by real-time PCR using group-specific primers. The
reactions were performed in real-time PCR detection
system (Agilent, USA). Each 25 μl reaction mixture con-
tained 12.5 μl of 2 × SYBR Green PCR Mix (TaKaRa,
Japan), 1 μl of each primer (20 μM) (Table 1), 1 μl of sam-
ple DNA and 9.1 μl of sterile deionized water. The different
bacteria did not share the same amplification program. For
Streptococcus pneumoniae, the procedure was set as one
cycle of 95°C for 30 s and then 40 cycles of 95°C for 5 s,
63°C for 30 s, and 72°C for 50 s. For Klebsiella pneumoniae,
the procedure involved one cycle at 94°C for 5 min, 40 cy-
cles at 94°C for 45 s, 54°C for 60 s, and 72°C for 45 s. For
Pseudomonas aeruginosa, the procedure involved in one
cycle of 95°C for 3 min, 40 cycles at 95°C for 15 s, 55°C for
30 s, and 72°C for 30 s. To obtain the melting curve, an
extra cycle was performed: 95°C for 1 min, 55°C for 30 s,
and 95°C for 30 s. A tenfold dilution series of plasmid DNA
containing target species DNA was used in each real-time
PCR assay to generate standard curves for quantitation of
target DNA in test samples. The correlation coefficient
values of the standard curves were limited from 0.99 to
1.0. Plasmid standards and samples were assayed simultan-
eously in three parallel PCR reactions.
Results
DGGE profiles analysis
The dominant respiratory microbiota of the COPD and
healthy group were show in Figure 1. Lanes 4–10 were
samples from the COPD group, whereas lane 1–3 repre-
sented those from the healthy individuals. The diversity
of respiratory microbiota from two groups was analyzed
with the Mann–Whitney U test to compare the Shan-
non–Weaver indexes of diversity (H’) of the bands from
Figure 1 V3 region of 16S rRNA gene profile from COPD group
(lane 4–10) and healthy group (lane 1–3) analyzed by DGGE.
Bands Bands A, B, C, D, E, 5 F,8 F,G and H were cut for sequencing.
Wu et al. BMC Pulmonary Medicine 2014, 14:179 Page 4 of 7
http://www.biomedcentral.com/1471-2466/14/179DGGE profile. It was clearly demonstrated that the di-
versity in the COPD groups significantly increased com-
pared with healthy groups (P < 0.05). The number of
bands was richer in the COPD group with a P value of
0.002 by the Mann–Whitney U test. The dendrogram
was constructed based on analysis of similarity score and
cluster from DGGE profiles by Phoretix 1D software
(Figure 2). Two groups formed significant clustering
profiles. There were two main clusters in the dendro-
gram. One was lane 1–3, related to the healthy group,
and the other was lane 4–10 involved in the COPD
group. The average number of bands, H’ and evenness
(E) between the two groups was listed in Table 2. Over-
all, the respiratory microbiota communities from the
COPD group had their own characteristics that were dif-
ferent from those of the healthy group.
Sequence analysis
Nine bands were selected and cut from the two groups for
sequencing in DGGE gels based on quantity analysis
(Figure 1). The obtained sequences were further analyzed
using a GenBank (NCBI) BLAST search (Table 3). To
verify the resolution of DGGE, two adjacent bands from
different lanes (5 F, 8 F) were cut and sequenced, and the
sequences indicated that both belonged to the Acinetobac-
ter calcoaceticus, indicating that the DGGE gel separated
V3 16S rRNA genes from different bacteria effectively. As
shown in the black frame from DGGE profile, the COPD
group shared a band at the same position, whereas there
was nearly no band at the corresponding place in the
healthy group. Some separated and strong bands (A, B, C,
D, E, G, and H) were identified as Facklamia hominis,
Prevotella melaninogenica, Zymomonas mobilis subsp. Mobilis,
Nitrosospira multiformis, Streptococcus sp., Bacteroides
vulgatus, and Veillonella sp.Real-time PCR analysis
Streptococcus pneumoniae, Klebsiella pneumoniae, and
Pseudomonas aeruginosa were chosen as typical import-
ant pulmonary bacterial groups for further quantitative
ananlysis. Streptococcus pneumoniae is a facultatively
anaerobic Gram-positive bacterium that normally resides
harmlessly within the human nasopharynx but is a major
cause of morbidity and mortality worldwide, causing
pneumonia. Klebsiella pneumoniae is a Gram-negative
bacterium. It is facultatively anaerobic. K. pneumoniae
is an important cause of human infections. Infections or
diseases are usually nosocomial or hospital-acquired.
The diseases caused by K. pneumoniae can result in the
death of patients who are immunodeficient. Pseudomonas
aeruginosa is a Gram-negative bacterium. Pseudomonas
aeruginosa is an opportunistic human pathogen. It is
always listed as one of the top three most frequent
Gram-negative pathogens and is linked to the worst dis-
ease outcomes. The copy numbers of each bacterium are
shown in Table 4. Streptococcus pneumoniae, Klebsiella
pneumoniae and Pseudomonas aeruginosa were increased
significantly in the COPD group compared with the
healthy group (P < 0.05). The data were reported as the
average estimate of the logarithms of sputum PCR target
genetic amplicon copy numbers present in 1 μl of sputum.
Results with P < 0.05 (Mann–Whitney U test) were con-
sidered significantly different.
Discussion
According to our results gained from PCR-DGGE profil-
ing techniques, there were multitude pathogens present
in all of the samples, which indicated the high sensitivity
of this molecular-based approach. Most of the detected
microorganisms were catalogued as uncultured bacteria.
However, certain most frequently isolated bacteria were
not found, such as Haemophilus spp and Moraxella
catarrhalis. In contrast to the routine culture-based
approach, in which we usually isolate individual patho-
gen, it is quite easy to detect multitude microbial patho-
gens at a high frequency. This notable phenomenon
implies that if we intend to define a given respiratory
system disease as a polymicrobial infection similar to the
cystic fibrosis-associated bronchiectasis, we can employ
the more sensitive molecular-based techniques.
With the sputum culture method, most prevalent bac-
terial isolation was Pseudomonas aeruginosa, which was
also identified with PCR-DGGE profiling techniques.
This bacterium is able produce mortality in some other
serious diseases [21]. A prior investigation suggested that
the occurrence of the acute exacerbations did not appear
to be correlated with the colonization of Pseudomonas
aeruginosa that much. However, the patients who were
colonized with Pseudomonas aeruginosa did visit hospi-
tals much more than people who were colonized with
Figure 2 Dendrogram of DGGE profiles analyzed by UPGMA method (COPD group: lane 4–10; healthy group: lane 1–3).







A Facklamia hominis Firmicutes 96%
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addition, the detection of Pseudomonas aeruginosa in
adult samples is much more frequent compared with
child samples [23].
Many previous studies have demonstrated that there
are some considerable individual variations in the micro-
bial community composition amongst patients. Thus, in
our study, we modeled the individual responses to time,
with patient as a random effect. As the data had been
derived from repeated measures, which was from a sub-
group of the sample population. Thus, it provides more
accurate information on the underlying polymicrobial
infection in sputum samples.
Currently, to analyze bactrial diversity, PCR-DGGE fin-
gerprinting and high-throughput pyrosequencing (NGS)
were two important and useful methods, which could
matched each other as two molecular analytical methods.
Just like all other microbiology methodologies, PCR-
DGGE fingerprinting, which is a conventional molecular
ecological approach, are not free from drawbacks. It has
been reported that DGGE only detected the predominant
microbiota and its separation has a bias against low-
abundance taxa in the community [24]. Muyzer et al.Table 2 Microbiota diversity index analysis of COPD and
healthy group





Number of bands (S) 14.43 ± 1.29 7.75 ± 0.25 0.002
Shannon–Weaver index (H’) 2.29 ± 0.24 1.85 ± 0.19 0.013
Evenness (E) 0.84 ± 0.09 0.96 ± 0.02 0.035indicated that only the bacterial species that accounted for
more than 1% out of the total microorganism prevalence
were identifiable on the DGGE gel [25]. Even so, DGGE
was currently considered as one of the few techniques that
allowed reproducible visual comparisons of profiles from
microbial communities and were successfully applied to a
wide variety of microbial ecosystems [26,27]. Pyrosequenc-
ing provided a high-throughput approach to analyze the
16S rRNA gene sequences and explore bacterial diversity
in different microhabitats deeply, which can compensate
for the disadvantage with the PCR-DGGE method in
detecting minor populations in microbiota [28]. This tech-
nique has been successfully used in various ecosystems
including fermented seafood [29], skin [30], chronic
wounds, oral microbiota [24] and so on.
In our study, we just aimed to better estimate the diver-
sity of the sputum community of the healthy and COPDB Prevotella melaninogenica Bacteroidetes 95%
C Zymomonas mobilis subsp.
mobilis
Proteobacteria 100%
D Nitrosospira multiformis Proteobacteria 100%
5 F, 8 F Acinetobacter calcoaceticus Proteobacteria 99%
E Streptococcus sp. Firmicutes 99%
G Bacteroides vulgatus Bacteroidetes 100%
H Veillonella sp. Firmicutes 99%
Table 4 Quantitation analysis of bacterial populations in






T test (p) value)
Streptococcus pneumoniae 9.48 ± 3.42 1.24 ± 1.78 0.001
Klebsiella pneumoniae 34.65 ± 31.47 6.26 ± 17.69 0.047
Pseudomonas aeruginosa 6.19 ± 1.81 1.44 ± 3.22 0.008
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vant to COPD. We first utilized PCR-DGGE with broad
range primers that correspond to the bacterial 16S rRNA
hypervariable V3 region to investigate the predominant
sputum microbiota in these populations. We also quanti-
fied the abundance of bacterial subgroups that associated
significantly with COPD using quantitative PCR (qPCR).
These methods are appropriate to achieve our above pur-
pose. Also, from other related studies, researchers pro-
posed that PCR-DGGE analysis could be used to monitor
the dramatic shift of bacterial transition and routinely
defined diseases in laboratory [31]. It’s economic and con-
venient. So in some research area for the large-scale
screenning of specific bacteria, this mehtod still occupy
the important position and widely used.
Recently, little work has been performed to examine
the contribution of the lung or lower respiratory tract
microbiome on the pathogenesis of pulmonary diseases.
Especially in inflammatory lung diseases such as asthma
and COPD, the local microbiome may play an important
role in the pathogenesis [32]. Purcell etc. analysed poly-
microbial airway bacterial communities in adult bronchi-
ectasis patients in sputum samples by culturing and
pyrosequencing approaches [33]. Also there are studies
about murine lung microbiome in relation to the intes-
tinal and vaginal bacterial communities by culturing and
pyrosequencing approaches [32]. Advancements in next
generation sequencing technology have provided means
for the comprehensive profiling of the microbial com-
munity in the respiratory tract in both physiological and
pathological conditions. Alexa describe the COPD lung
microbiome of 22 patients with moderate or severe
COPD compared to 10 healthy control patients. The
composition of the lung microbiomes was determined
using 454 pyrosequencing of 16S rDNA found in bron-
choalveolar lavage fluid (BALF) [34]. The results showed
a significant increase in microbial diversity with the de-
velopment of COPD. The main phyla in all samples were
Actinobacteria, Firmicutes, and Proteobacteria. Although
our study hold different experimental purposes, adopted
different samples and methods compared with this in-
vestigation, the results obtained are the same in some
degree.
In a summary, for clinical prevention and diagnosis of
COPD in the process of introducing this new respiratorytract flora observed targets. Improve the clinical type of
high-maintenance rate of pathogenic bacteria, the medi-
cation for instruction, is of great significance to improve
the treatment effect of COPD.
Conclusion
This study have provided a relatively comprehensive pic-
ture of our current knowledge of the community struc-
ture of the COPD sputum bacterial ecosystem and
revealed strong relationship between alterations of spu-
tum microbiota and COPD. By determining the content
of several types of potential pathogenic populations, we
can provide evidence to aid in the diagnosis and treat-
ment of COPD. It is therefore necessary to further study
the variations of the respiratory microbiota with the de-
velopment of COPD.
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